Author response for 'Efficacy and Safety of Liraglutide in Type 1 Diabetes by Baseline Characteristics in the ADJUNCT ONE and ADJUNCT TWO Randomized Clinical Trials'

Autor:	Lars Bardtrum, Frederik Flindt Kreiner, Two Investigators, Thomas F. Dejgaard, Sten Madsbad, Chantal Mathieu, Erik Christiansen, Bernt Johan von Scholten, Matthias von Herrath
Rok vydání:	2021
Předmět:	Type 1 diabetes medicine.medical_specialty Liraglutide business.industry medicine.disease Adjunct law.invention Randomized controlled trial law Baseline characteristics Internal medicine medicine business medicine.drug
DOI:	10.1111/dom.14532/v2/response1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::175335eb3d75807dcef4b8c3a42a2cd5 https://doi.org/10.1111/dom.14532/v2/response1 Zobrazit plný text záznamu